Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Identification of Immune complement function as a determinant of adverse SARS-CoV-2 infection outcome

Vijendra Ramlall, Phyllis M. Thangaraj, Cem Meydan, Jonathan Foox, Daniel Butler, Ben May, Jessica K. De Freitas, Benjamin S. Glicksberg, View ORCID ProfileChristopher E. Mason, Nicholas P. Tatonetti, Sagi D. Shapira
doi: https://doi.org/10.1101/2020.05.05.20092452
Vijendra Ramlall
1Department of Biomedical Informatics, Columbia University, New York, NY, USA. USA.
2Department of Physiology & Cellular Biophysics, Columbia University, New York, NY, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Phyllis M. Thangaraj
1Department of Biomedical Informatics, Columbia University, New York, NY, USA. USA.
3Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cem Meydan
5The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA
6Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan Foox
4Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA
5The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Butler
4Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA
5The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ben May
6Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica K. De Freitas
7Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, 10029
8Hasso Plattner Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY, 10065
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin S. Glicksberg
7Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, 10029
8Hasso Plattner Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY, 10065
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher E. Mason
4Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA
5The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA
9The WorldQuant Initiative for Quantitative Prediction, Weill Cornell Medicine, New York, NY, USA
10The Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christopher E. Mason
Nicholas P. Tatonetti
1Department of Biomedical Informatics, Columbia University, New York, NY, USA. USA.
11Department of Systems Biology, Columbia University, New York, NY, USA. USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: nick.tatonetti@columbia.edu ss4197@columbia.edu
Sagi D. Shapira
11Department of Systems Biology, Columbia University, New York, NY, USA. USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: nick.tatonetti@columbia.edu ss4197@columbia.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Summary

Understanding the pathophysiology of SARS-CoV-2 infection is critical for therapeutics and public health intervention strategies. Viral-host interactions can guide discovery of regulators of disease outcomes, and protein structure function analysis points to several immune pathways, including complement and coagulation, as targets of the coronavirus proteome. To determine if conditions associated with dysregulation of the complement or coagulation systems impact adverse clinical outcomes, we performed a retrospective observational study of 11,116 patients who presented with suspected SARS-CoV-2 infection. We found that history of macular degeneration (a proxy for complement activation disorders) and history of coagulation disorders (thrombocytopenia, thrombosis, and hemorrhage) are risk factors for morbidity and mortality in SARS-CoV-2 infected patients - effects that could not be explained by age, sex, or history of smoking. Further, transcriptional profiling of nasopharyngeal (NP) swabs from 650 control and SARS-CoV-2 infected patients demonstrated that in addition to innate Type-I interferon and IL-6 dependent inflammatory immune responses, infection results in robust engagement and activation of the complement and coagulation pathways. Finally, we conducted a candidate driven genetic association study of severe SARS-CoV-2 disease. Among the findings, our scan identified putative complement and coagulation associated loci including missense, eQTL and sQTL variants of critical regulators of the complement and coagulation cascades. In addition to providing evidence that complement function modulates SARS-CoV-2 infection outcome, the data point to putative transcriptional genetic markers of susceptibility. The results highlight the value of using a multi-modal analytical approach, combining molecular information from virus protein structure-function analysis with clinical informatics, transcriptomics, and genomics to reveal determinants and predictors of immunity, susceptibility, and clinical outcome associated with infection.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was funded by NIH grants 5R01GM109018 and 5U54CA209997 to SS, R35GM131905 to NPT, F30HL140946 to PT, and equipment grants S10OD012351 and S10OD021764 to the Columbia University Department of Systems Biology. CEM would like to thank the Scientific Computing Unit (SCU), XSEDE Supercomputing Resources, the Starr Cancer Consortium (I13-0052), and funding from the WorldQuant Foundation, The Pershing Square Sohn Cancer Research Alliance, NASA (NNX14AH50G, NNX17AB26G), the National Institutes of Health (R21AI129851, R01MH117406, R01AI151059).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study is approved by the Columbia University Irving Medical Center Institutional Review Board (IRB# AAAL0601) and the requirement for an informed consent was waived. A data request associated with this protocol was submitted to the Tri-Institutional Request Assessment Committee (TRAC) of New-York Presbyterian, Columbia, and Cornell and approved. The research on the UK Biobank data has been conducted using the UK Biobank Resource under Application Number 41039. The transcriptomics analysis samples were collected and processed through the Weill Cornell Medicine Institutional Review Board (IRB) Protocol 19-11021069.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Our data from NYP/CUIMC are protected by HIPAA and cannot be released. UK Biobank data are available through their application process. In addition, we are updating online summary data as additional patient data become available.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted June 06, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Identification of Immune complement function as a determinant of adverse SARS-CoV-2 infection outcome
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Identification of Immune complement function as a determinant of adverse SARS-CoV-2 infection outcome
Vijendra Ramlall, Phyllis M. Thangaraj, Cem Meydan, Jonathan Foox, Daniel Butler, Ben May, Jessica K. De Freitas, Benjamin S. Glicksberg, Christopher E. Mason, Nicholas P. Tatonetti, Sagi D. Shapira
medRxiv 2020.05.05.20092452; doi: https://doi.org/10.1101/2020.05.05.20092452
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Identification of Immune complement function as a determinant of adverse SARS-CoV-2 infection outcome
Vijendra Ramlall, Phyllis M. Thangaraj, Cem Meydan, Jonathan Foox, Daniel Butler, Ben May, Jessica K. De Freitas, Benjamin S. Glicksberg, Christopher E. Mason, Nicholas P. Tatonetti, Sagi D. Shapira
medRxiv 2020.05.05.20092452; doi: https://doi.org/10.1101/2020.05.05.20092452

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (76)
  • Allergy and Immunology (199)
  • Anesthesia (54)
  • Cardiovascular Medicine (492)
  • Dentistry and Oral Medicine (90)
  • Dermatology (57)
  • Emergency Medicine (169)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (214)
  • Epidemiology (5722)
  • Forensic Medicine (3)
  • Gastroenterology (217)
  • Genetic and Genomic Medicine (872)
  • Geriatric Medicine (89)
  • Health Economics (232)
  • Health Informatics (768)
  • Health Policy (395)
  • Health Systems and Quality Improvement (254)
  • Hematology (105)
  • HIV/AIDS (185)
  • Infectious Diseases (except HIV/AIDS) (6527)
  • Intensive Care and Critical Care Medicine (393)
  • Medical Education (118)
  • Medical Ethics (28)
  • Nephrology (93)
  • Neurology (851)
  • Nursing (44)
  • Nutrition (142)
  • Obstetrics and Gynecology (164)
  • Occupational and Environmental Health (263)
  • Oncology (516)
  • Ophthalmology (165)
  • Orthopedics (44)
  • Otolaryngology (107)
  • Pain Medicine (48)
  • Palliative Medicine (21)
  • Pathology (149)
  • Pediatrics (252)
  • Pharmacology and Therapeutics (147)
  • Primary Care Research (114)
  • Psychiatry and Clinical Psychology (981)
  • Public and Global Health (2250)
  • Radiology and Imaging (378)
  • Rehabilitation Medicine and Physical Therapy (174)
  • Respiratory Medicine (313)
  • Rheumatology (109)
  • Sexual and Reproductive Health (82)
  • Sports Medicine (82)
  • Surgery (118)
  • Toxicology (25)
  • Transplantation (34)
  • Urology (42)